Endovascular Management of Chronic Symptomatic Aortic Dissection (CSAD) With the Streamliner Multilayer Flow Modulator (SMFM): 12-Month Outcomes from the Global Registry

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume63
Publication statusPublished - 1 Jun 2016

Cite this